Sharlene Gill, BScPharm, MD, MPH, MBA, FRCPC, discusses patient experiences and involvement in decision-making in CRC.
Sharlene Gill, MD, MPH, MBA, FRCPC
Advertisement
Sharlene Gill, MD, MPH, MBA, FRCPC, is a professor in the Department of Medicine in the Division of Medical Oncology at The University of British Columbia in Canada.
Articles by Sharlene Gill, MD, MPH, MBA, FRCPC
Sharlene Gill, BScPharm, MD, MPH, MBA, FRCPC, discusses the rationale for evaluating patient experiences and involvement in CRC treatment decision-making.
Sharlene Gill, MD, MPH, MBA, FRCPC, highlights the importance of considering patients’ concerns ahead of treatment decision-making for advanced CRC.
Advertisement
Latest Updated Articles
Dr Gill on a Survey of Patient Experiences and Involvement in Decision-Making in CRCPublished: September 19th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5